Compare NKSH & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NKSH | INFU |
|---|---|---|
| Founded | 1891 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.8M | 208.8M |
| IPO Year | 1995 | 2005 |
| Metric | NKSH | INFU |
|---|---|---|
| Price | $36.80 | $8.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 56.3K | ★ 170.9K |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.22% | N/A |
| EPS Growth | 100.81 | ★ 181.82 |
| EPS | ★ 2.49 | 0.05 |
| Revenue | $8,176,000.00 | ★ $143,436,000.00 |
| Revenue This Year | N/A | $3.20 |
| Revenue Next Year | N/A | $7.31 |
| P/E Ratio | ★ $13.90 | $167.00 |
| Revenue Growth | ★ 9.39 | 6.36 |
| 52 Week Low | $24.74 | $5.08 |
| 52 Week High | $40.00 | $11.04 |
| Indicator | NKSH | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 36.75 | 36.48 |
| Support Level | $27.59 | $7.31 |
| Resistance Level | $35.00 | $10.84 |
| Average True Range (ATR) | 1.43 | 0.56 |
| MACD | -0.19 | -0.25 |
| Stochastic Oscillator | 0.56 | 18.75 |
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural loans, commercial real estate, construction loans for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary. The company earns its revenue from interest and fees on loans, non-interest income, and investments.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.